News Daily News NOBLE at 5 Years: New Data Favor CABG for Left Main Disease Todd Neale December 23, 2019
News Daily News Carotid Stenting Makes a Strong Showing in the CREST-2 Registry Todd Neale December 23, 2019
News Daily News CvLPRIT: Long-term Reduction in Death/MI With Complete Revascularization Michael O'Riordan December 20, 2019
News Daily News FDA Approves Icosapent Ethyl for Reducing CVD Events Michael O'Riordan December 13, 2019
News Daily News Hypothermia Boosts 90-Day Function for Nonshockable Cardiac Arrest Caitlin E. Cox December 13, 2019
News Daily News EACTS Pulls Out of Left Main Guidelines After BBC Bombshell Alleging EXCEL Trial Cover-up Michael O'Riordan December 10, 2019
News Daily News FDA Advisors Recommend CVD Event Reduction Claim for Icosapent Ethyl Michael O'Riordan November 14, 2019
News Daily News Lipid Levels Declining in US, With Drops Seen After 2013 Guideline Release Michael O'Riordan November 11, 2019
News Daily News Noninvasive Tests for Chest Pain: New Insight Into Who Benefits Most Yael L. Maxwell November 07, 2019
News Daily News Vasospasm, Microvascular Dysfunction Tied to MACE in Nonobstructive CAD Michael O'Riordan November 05, 2019
News Daily News Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’ L.A. McKeown October 29, 2019
News Daily News Multiarterial CABG ‘Underused’ in Contemporary Practice, Decreases Mortality Yael L. Maxwell October 28, 2019
News Daily News New Review Questions Statin Benefit in Lower-Risk Primary Prevention Patients Michael O'Riordan October 22, 2019
News Daily News Believing SCOT-HEART: New Analysis Probes Plausible Mechanisms of Benefit Shelley Wood October 14, 2019
News Daily News Recurrent Events Common Among Young Patients With CAD Michael O'Riordan October 11, 2019
News Daily News PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’ Shelley Wood October 08, 2019
News Daily News Interventional Options and Future Directions for Acute PE: New AHA Statement Todd Neale October 07, 2019
News Daily News Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES Michael O'Riordan August 26, 2019
News Daily News DOACs Good for Secondary Prevention in Older A-fib Patients, Real-world Numbers Affirm Todd Neale July 23, 2019